January 2008 Archives - Silence Therapeutics

News	Events
Publications	Companies
Clinical Trials

Galena Biopharma Announces Investigational New Drug Approval for Phase 2 Trial for NeuVax(TM) (E75 + GM-CSF) Combined With Herceptin(R) (trastuzumab)
0 Replies

January 23, 2008

LAKE OSWEGO, Ore., Jan. 5, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that the U.S. Food and Drug Administration has approved the Investigational New Drug (IND) application for the... Contine Reading & Discuss→

Posted in News

Holding in Company
0 Replies

January 21, 2008

Contine Reading & Discuss→

Posted in News and Events

Holding(s) in Company
0 Replies

January 17, 2008

Contine Reading & Discuss→

Posted in News and Events

Holding in Company
0 Replies

January 12, 2008

Contine Reading & Discuss→

Posted in News and Events

Holding in Company
0 Replies

January 02, 2008

Contine Reading & Discuss→

Posted in News and Events

Holding in Company
0 Replies

Contine Reading & Discuss→

Posted in News and Events

Holding in Company
0 Replies

January 01, 2008

Contine Reading & Discuss→

Posted in News and Events